Volume | 101,543 |
|
|||||
News | - | ||||||
Day High | 0.8794 | Low High |
|||||
Day Low | 0.803 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Mainz BioMed NV | MYNZ | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.8655 | 0.803 | 0.8794 | 0.8568 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
312 | 101,543 | $ 0.837518 | $ 85,044 | - | 0.803 - 6.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:03:20 | 491 | $ 0.8115 | USD |
Mainz BioMed NV Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
0 | 14.83M | - | 895k | -26.3M | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Mainz BioMed NV News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYNZ Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.89 | 1.08 | 0.803 | 0.8623892 | 270,735 | -0.0785 | -8.82% |
1 Month | 1.06 | 1.13 | 0.803 | 0.9278753 | 116,068 | -0.2485 | -23.44% |
3 Months | 0.95 | 1.22 | 0.803 | 0.963 | 100,215 | -0.1385 | -14.58% |
6 Months | 2.04 | 3.3923 | 0.803 | 1.18 | 169,438 | -1.23 | -60.22% |
1 Year | 3.20 | 6.00 | 0.803 | 2.08 | 123,884 | -2.39 | -74.64% |
3 Years | 14.35 | 30.00 | 0.803 | 9.66 | 138,597 | -13.54 | -94.34% |
5 Years | 14.35 | 30.00 | 0.803 | 9.66 | 138,597 | -13.54 | -94.34% |
Mainz BioMed NV Description
Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results. |